Nonadherence among HIV-Infected injecting drug users: The impact of social instability

被引:109
作者
Bouhnik, AD
Chesney, M
Carrieri, P
Gallais, H
Moreau, J
Moatti, JP
Obadia, Y
Spire, B
机构
[1] INSERM, U379, F-13006 Marseille, France
[2] Reg Ctr Dis Control SE France, ORS PACA, Marseille, France
[3] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA
[4] Hop Conception, Marseille, France
[5] Hop Nord Marseille, Marseille, France
关键词
D O I
10.1097/00126334-200212153-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The authors tested the impact of social instability on adherence to highly active antiretroviral therapy (HAART) among patients infected with HIV through injection drug use (IDU; MANIF2000 cohort). In the study, they analyzed sociodemographic baseline characteristics to develop an indicator of social instability. Information concerning adherence to HAART was collected through questionnaires during a 2-year follow-up period. Factors associated with nonadherence were studied in two different groups: 1) patients who had stopped injection drug use (ex-IDUs) and who were not in drug maintenance programs (DMT) during the entire follow-up period, and 2) those who were still opiate dependent. Among the 210 eligible patients, 114 were classified as ex-IDUs and 96 as opiate dependent. Ex-IDUs reported nonadherence behaviors in 96 of 384 visits (25.0%), while opiate-dependent patients were nonadherent in I I I of 308 visits (36.0%; p = .02). Among ex-IDUs, the only factor associated with nonadherence was social instability, while among opiate-dependent patients, injection behavior was the only determinant of nonadherence behavior. For opiate-dependent patients, DMT may enhance adherence to HAART, but only if it is successful in reducing abuse of injection practices. For ex-IDUs, it is very important that the management of social difficulties be taken into account to increase adherence to HAART.
引用
收藏
页码:S149 / S153
页数:5
相关论文
共 29 条
[1]  
Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
[2]  
[Anonymous], 2000, LANCET, V355, P1158
[3]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[4]  
CARRIERI M, 2002, IN PRESS INT J BEHAV
[5]  
Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005
[6]   Adherence to HIV combination therapy [J].
Chesney, MA ;
Morin, M ;
Sherr, L .
SOCIAL SCIENCE & MEDICINE, 2000, 50 (11) :1599-1605
[7]   'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study [J].
Duran, S ;
Solas, C ;
Spire, B ;
Carrieri, MP ;
Fuzibet, JG ;
Costagliola, D ;
Lacarelle, B ;
Moatti, JP .
AIDS, 2001, 15 (08) :1075-1077
[8]  
Fhima A, 2001, ANN MED INTERNE, V152, pS26
[9]   Sociodemographic and psychological variables influencing adherence to antiretroviral therapy [J].
Gordillo, V ;
del Amo, J ;
Soriano, V ;
González-Lahoz, J .
AIDS, 1999, 13 (13) :1763-1769
[10]   Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study (NTORS) [J].
Gossop, M ;
Marsden, J ;
Stewart, D ;
Rolfe, A .
DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (03) :275-286